Lyell Immunopharma
LYEL
#7631
Rank
NZ$0.80 B
Marketcap
NZ$25.23
Share price
1.62%
Change (1 day)
-25.95%
Change (1 year)

Earnings for Lyell Immunopharma (LYEL)

Earnings in 2026 (TTM): -NZ$0.45 Billion

According to Lyell Immunopharma's latest financial reports the company's current earnings are NZ$0.01 Million. In 2025 the company made an earning of -NZ$0.51 Billion, an increase over its 2024 earnings that were of -NZ$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lyell Immunopharma from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.45 Billion-11.38%
2025 -NZ$0.51 Billion-19.98%
2024 -NZ$0.63 Billion46.18%
2023 -NZ$0.43 Billion28.13%
2022 -NZ$0.34 Billion-26.82%
2021 -NZ$0.46 Billion22.37%
2020 -NZ$0.38 Billion